Clinical Trial Update: Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating low-dose atropine eye drops to slow myopia progression in children in the United Kingdom.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• low-dose atropine eye drops (atropine)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Myopia | Phase 2 | Status: ACTIVE_NOT_RECRUITING